Unity Biotechnology
| Use attributes for filter ! | |
| Stock price | UBX |
|---|---|
| Disclaimer | |
| Founded | 2011 |
| Headquarters | Brisbane |
| California | |
| United States | |
| Number of employees | 70 (2018) |
| Founders | Nathaniel David |
| Nathaniel “Ned” David | |
| Jan van Deursen | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1165327 |
About Unity Biotechnology
Unity Biotechnology is a startup biotechnology company that develops drugs which target senescent cells. The company's products in development include UBX0101, targeting knee osteoarthritis, and UBX1967, a preclinical product targeting ophthalmologic diseases. Both are senolytic medicines.
